CHAPTER 1:INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY MARKET SEGMENTS
1.3.KEY BENEFITS
1.4.RESEARCH METHODOLOGY

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO PERSPECTIVE

CHAPTER 3:MARKET OVERVIEW


3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.MARKET DYNAMICS

3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities

CHAPTER 4:STD TESTING MARKET BY DISEASE TYPE

4.1.OVERVIEW
4.2. CHLAMYDIA

4.2.1.Key market trends, Growth factors and opportunities
4.2.2.Market size and forecast by region
4.2.3.Market volume and forecast by region

4.3. GONORRHEA

4.3.1.Key market trends, Growth factors and opportunities
4.3.2.Market size and forecast by region
4.3.3.Market volume and forecast by region

4.4. HERPES SIMPLEX VIRUS

4.4.1.Key market trends, Growth factors and opportunities
4.4.2.Market size and forecast by region
4.4.3.Market volume and forecast by region

4.5. SYPHILIS

4.5.1.Key market trends, Growth factors and opportunities
4.5.2.Market size and forecast by region
4.5.3.Market volume and forecast by region

4.6. HUMAN PAPILLOMA VIRUS

4.6.1.Key market trends, Growth factors and opportunities
4.6.2.Market size and forecast by region
4.6.3.Market volume and forecast by region

4.7. HUMAN IMMUNODEFICIENCY VIRUS

4.7.1.Key market trends, Growth factors and opportunities
4.7.2.Market size and forecast by region
4.7.3.Market volume and forecast by region

4.8. OTHERS

4.8.1.Key market trends, Growth factors and opportunities
4.8.2.Market size and forecast by region
4.8.3.Market volume and forecast by region

CHAPTER 5:STD TESTING MARKET BY LOCATION OF TESTING

5.1.OVERVIEW
5.2. LABORATORY TESTING

5.2.1.Key market trends, Growth factors and opportunities
5.2.2.Market size and forecast by region
5.2.3.Market volume and forecast by region

5.3. POINT OF CARE TESTING

5.3.1.Key market trends, Growth factors and opportunities
5.3.2.Market size and forecast by region
5.3.3.Market volume and forecast by region

CHAPTER 6:STD TESTING MARKET BY REGION

6.1.OVERVIEW
6.2.NORTH AMERICA

6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast by Disease Type
6.2.3.Market size and forecast by Location of Testing

6.3.EUROPE

6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast by Disease Type
6.3.3.Market size and forecast by Location of Testing

6.4.ASIA PACIFIC

6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast by Disease Type
6.4.3.Market size and forecast by Location of Testing

6.5.LAMEA

6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast by Disease Type
6.5.3.Market size and forecast by Location of Testing

CHAPTER 7:COMPANY PROFILES

7.1. ROCHE HOLDINGS AG

7.1.1.Company overview
7.1.2.Business performance
7.1.3.Key strategic moves and developments

7.2. BIOMERIEUX

7.2.1.Company overview
7.2.2.Business performance
7.2.3.Key strategic moves and developments

7.3. HOLOGIC INC

7.3.1.Company overview
7.3.2.Business performance
7.3.3.Key strategic moves and developments

7.4. BECTON DICKINSON COMPANY

7.4.1.Company overview
7.4.2.Business performance
7.4.3.Key strategic moves and developments

7.5. ORASURE

7.5.1.Company overview
7.5.2.Business performance
7.5.3.Key strategic moves and developments

7.6. DANAHER CORPORATION

7.6.1.Company overview
7.6.2.Business performance
7.6.3.Key strategic moves and developments

7.7. AFFYMETRIX

7.7.1.Company overview
7.7.2.Business performance
7.7.3.Key strategic moves and developments

7.8. ABBOTT LABORATORIES

7.8.1.Company overview
7.8.2.Business performance
7.8.3.Key strategic moves and developments

7.9. BIO-RAD LABORATORIES INC

7.9.1.Company overview
7.9.2.Business performance
7.9.3.Key strategic moves and developments

7.10. DIASORIN

7.10.1.Company overview
7.10.2.Business performance
7.10.3.Key strategic moves and developments

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.